Regeneron resumes enrollment in lymphoma drug trials

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 17, 2021 at 11:12 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via Regeneron Pharmaceuticals (REGN.O) said on Monday it was resuming the enrollment of patients in two studies testing its experimental lymphoma drug after the U.S. Food and Drug Administration agreed to lift its partial clinical hold.

    article source